Back to Search Start Over

Pericardial Diseases in Pregnancy.

Authors :
Serati L
Mardigyan V
Dominioni CC
Agozzino F
Bizzi E
Trotta L
Nivuori M
Maestroni S
Negro E
Imazio M
Brucato A
Source :
The Canadian journal of cardiology [Can J Cardiol] 2023 Aug; Vol. 39 (8), pp. 1067-1077. Date of Electronic Publication: 2023 Apr 20.
Publication Year :
2023

Abstract

Pericardial effusion is the most common manifestation of pericardial diseases during pregnancy. This effusion is benign, mild, or moderate, well tolerated, with spontaneous resolution after delivery; no specific treatment is required. Acute pericarditis is the second most common condition, usually requiring medical therapy during pregnancy. Cardiac tamponade and constrictive pericarditis are rare in pregnancy. Pre-pregnancy counselling is essential in women of childbearing age with recurrent pericarditis to plan pregnancy in a phase of disease quiescence and to review therapy. High-dose aspirin or nonselective nonsteroidal anti-inflammatory drugs, such as ibuprofen and indomethacin, can be used up to the 20th week of gestation. Low-dose prednisone (2.5-10 mg/d) can be administered throughout pregnancy. All of these medications, apart from high-dose aspirin, may be used during lactation. Colchicine is compatible with pregnancy and breastfeeding, and it can be continued throughout pregnancy to prevent recurrences. Appropriate follow-up with a multidisciplinary team with experience in the field is recommended throughout pregnancy to ensure good maternal and fetal outcomes.<br /> (Copyright © 2023 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1916-7075
Volume :
39
Issue :
8
Database :
MEDLINE
Journal :
The Canadian journal of cardiology
Publication Type :
Academic Journal
Accession number :
37086835
Full Text :
https://doi.org/10.1016/j.cjca.2023.04.010